Published in Mol Cancer Ther on June 01, 2007
High risk HPV types 18 and 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro. Infect Agent Cancer (2007) 0.96
NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC). FEBS Open Bio (2013) 0.89
Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC). Br J Cancer (2014) 0.87
Folic acid supplementation increases survival and modulates high risk HPV-induced phenotypes in oral squamous cell carcinoma cells and correlates with p53 mRNA transcriptional down-regulation. Cancer Cell Int (2012) 0.76
Id3 induces an Elk-1-caspase-8-dependent apoptotic pathway in squamous carcinoma cells. Cancer Med (2015) 0.76
Guidelines for the next 10 years of proteomics. Proteomics (2006) 3.61
Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev Cell (2002) 2.98
Cancer classification using the Immunoscore: a worldwide task force. J Transl Med (2012) 2.88
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res (2002) 2.86
A novel human primary immunodeficiency syndrome caused by deficiency of the endosomal adaptor protein p14. Nat Med (2006) 2.85
Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32
MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity. Nat Genet (2008) 2.24
Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways. Immunity (2011) 2.20
Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Neoplasia (2005) 2.18
Integrin-linked kinase controls microtubule dynamics required for plasma membrane targeting of caveolae. Dev Cell (2010) 2.17
p14-MP1-MEK1 signaling regulates endosomal traffic and cellular proliferation during tissue homeostasis. J Cell Biol (2006) 2.15
Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature (2009) 2.05
Noninvasive detection of lung cancer by analysis of exhaled breath. BMC Cancer (2009) 1.99
Comm sorts robo to control axon guidance at the Drosophila midline. Cell (2002) 1.98
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". J Transl Med (2008) 1.77
The nuclear orphan receptor NR2F6 suppresses lymphocyte activation and T helper 17-dependent autoimmunity. Immunity (2008) 1.73
Preventive therapy for breast cancer: a consensus statement. Lancet Oncol (2011) 1.69
Bicaudal D induces selective dynein-mediated microtubule minus end-directed transport. EMBO J (2003) 1.65
Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry. Clin Chem Lab Med (2009) 1.64
Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. Int J Radiat Oncol Biol Phys (2003) 1.57
The late endosomal adaptor molecule p14 (LAMTOR2) represents a novel regulator of Langerhans cell homeostasis. Blood (2013) 1.54
Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. J Natl Cancer Inst (2002) 1.52
Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. Eur J Radiol (2003) 1.52
Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol (2003) 1.51
Crystal structure of the p14/MP1 scaffolding complex: how a twin couple attaches mitogen-activated protein kinase signaling to late endosomes. Proc Natl Acad Sci U S A (2004) 1.43
Low incidence of mutations in EGFR kinase domain in Caucasian patients with head and neck squamous cell carcinoma. Eur J Cancer (2005) 1.35
Paxillin-dependent stimulation of microtubule catastrophes at focal adhesion sites. J Cell Sci (2008) 1.34
Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome. PLoS Pathog (2009) 1.28
Identification of vaccine candidate antigens of Staphylococcus aureus by serological proteome analysis. Proteomics (2002) 1.27
Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network. Proteomics (2008) 1.27
Phosphoproteomics strategies for the functional analysis of signal transduction. Proteomics (2006) 1.26
Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer. Clin Cancer Res (2002) 1.22
Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model. Hum Mutat (2010) 1.20
(68)Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate? Eur J Nucl Med Mol Imaging (2015) 1.18
The last but not the least: the origin and significance of trailing adhesions in fibroblastic cells. Cell Motil Cytoskeleton (2005) 1.08
Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Oncogene (2002) 1.08
TIS7 interacts with the mammalian SIN3 histone deacetylase complex in epithelial cells. EMBO J (2002) 1.07
Zooming in: fractionation strategies in proteomics. Proteomics (2004) 1.06
Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis (2006) 1.06
Rapid sample preparation and simultaneous quantitation of prostaglandins and lipoxygenase derived fatty acid metabolites by liquid chromatography-mass spectrometry from small sample volumes. Clin Chem Lab Med (2008) 1.05
Phosphorylation-regulated cleavage of the reticulon protein Nogo-B by caspase-7 at a noncanonical recognition site. Proteomics (2007) 1.04
EGFR inhibition as a therapy for head and neck squamous cell carcinoma. Expert Opin Investig Drugs (2008) 1.04
Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells. Proteomics (2008) 1.03
Enrichment of low-abundant serum proteins by albumin/immunoglobulin G immunoaffinity depletion under partly denaturing conditions. Electrophoresis (2005) 1.01
Proteomics profiling of microdissected low- and high-grade prostate tumors identifies Lamin A as a discriminatory biomarker. J Proteome Res (2010) 1.00
Muscle regeneration and myogenic differentiation defects in mice lacking TIS7. Mol Cell Biol (2004) 0.99
Providing psychosocial support for breast cancer patients based on screening for distress within a consultation-liaison service. Psychooncology (2004) 0.99
Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse. Radiother Oncol (2010) 0.99
Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells. J Radiat Res (2005) 0.99
Epidemiological aspects of hadron therapy: a prospective nationwide study of the Austrian project MedAustron and the Austrian Society of Radiooncology (OEGRO). Radiother Oncol (2004) 0.98
Signaling function of alpha-catenin in microtubule regulation. Cell Cycle (2008) 0.98
Identification of endosomal epidermal growth factor receptor signaling targets by functional organelle proteomics. Mol Cell Proteomics (2007) 0.98
Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys (2008) 0.98
Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity. Traffic (2013) 0.98
Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J Cardiovasc Magn Reson (2002) 0.98
Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol (2008) 0.97
Major flavonoid components of heartsease (Viola tricolor L.) and their antioxidant activities. Anal Bioanal Chem (2008) 0.95
Discovery of N-(4-methoxyphenyl)-N,2-dimethylquinazolin-4-amine, a potent apoptosis inducer and efficacious anticancer agent with high blood brain barrier penetration. J Med Chem (2009) 0.95
Role of TIS7 family of transcriptional regulators in differentiation and regeneration. Differentiation (2007) 0.95
Apoptosis resistance of senescent human fibroblasts is correlated with the absence of nuclear IGFBP-3. Aging Cell (2005) 0.94
Isolation of endocitic organelles by density gradient centrifugation. Methods Mol Biol (2008) 0.93
Pilot study: volatile organic compounds as a diagnostic marker for head and neck tumors. Head Neck (2008) 0.93
QIKS--Quantitative identification of kinase substrates. Proteomics (2010) 0.91
Identification of novel ribonucleo-protein complexes from the brain-specific snoRNA MBII-52. RNA (2010) 0.91
High capacity organic monoliths for the simultaneous application to biopolymer chromatography and the separation of small molecules. J Chromatogr A (2009) 0.91
Reassessing the role of phosphocaveolin-1 in cell adhesion and migration. Traffic (2007) 0.90
Balance ability and muscle response of the preferred and nonpreferred leg in soccer players. Motor Control (2009) 0.90
MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps. Cancer Res (2007) 0.90
A genome-wide RNAi screen in mouse embryonic stem cells identifies Mp1 as a key mediator of differentiation. J Exp Med (2011) 0.89
Intraoperative radiotherapy of soft tissue sarcoma of the extremity. Strahlenther Onkol (2004) 0.88
Value of infliximab (Remicade®) in patients with low-risk myelodysplastic syndrome: final results of a randomized phase II trial (EORTC trial 06023) of the EORTC Leukemia Group. Haematologica (2011) 0.87
Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI). Magn Reson Imaging (2003) 0.87
Quantitative detection of phosphoproteins by combination of two-dimensional difference gel electrophoresis and phosphospecific fluorescent staining. Electrophoresis (2005) 0.87
Protein sites of attack of N-chlorotaurine in Escherichia coli. Proteomics (2006) 0.87